Table 2.
Overview of adverse events in participants who received the allocated intervention.
Adverse event type | All (n) | Vitamin D3 (n) | Placebo (n) |
---|---|---|---|
Relapse | 1 | 1 | 1 |
Hypercalciuria | 5 | 2 | 3 |
Hypocalcemia | 0 | 0 | 0 |
Infections | |||
Urinary tract infection | 6 | 3 | 3 |
Pharyngitis | 1 | 1 | 0 |
Ear infection | 2 | 1 | 1 |
Herpes zoster infection | 1 | 1 | 0 |
Influenza | 3 | 0 | 3 |
Upper respiratory tract infection | 4 | 1 | 3 |
Gastrointestinal | |||
Abdominal pain | 1 | 0 | 1 |
Stomach discomfort | 1 | 0 | 1 |
Cardiovascular | |||
Hypertension | 1 | 0 | 1 |
Hypercholesterolemia | 1 | 0 | 1 |
Cold extremities | 1 | 0 | 1 |
Musculoskeletal | |||
Lumbago | 1 | 0 | 1 |
Leg pains | 1 | 1 | 0 |
Ruptured ankle ligaments | 1 | 0 | 1 |
Achilles tendinosis | 1 | 0 | 1 |
Lateral epicondylitis | 1 | 0 | 1 |
Other | |||
Pregnancy | 1 | 0 | 1 |
Iron deficiency | 1 | 0 | 1 |
Headaches | 2 | 2 | 0 |
Fatigue | 2 | 1 | 1 |
Dizziness | 2 | 2 | 0 |
Axillary pains | 1 | 1 | 0 |
Globus/tingling sensations during swallowing | 2 | 2 | 0 |
Mood swings | 2 | 2 | 0 |
Suicidal thoughts | 1 | 0 | 1 |